Preventing Nerve Damage Induced by Chemotherapy

Not Applicable

Completed

• Conditions: Oxaliplatin induced Neurotoxicity; Peripheral neuropathy; Colorectal cancer; Cancer - Bowel - Back passage (rectum) or large bowel (colon); Neurological - Other neurological disorders

• Registration Number: ACTRN12611000738921
• Lead Sponsor: Dr Mark McKeage

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2011-07-14
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 12

Inclusion Criteria

Histologically proven colorectal cancer, eligible for standard oxaliplatin based chemotherapy, written informed consent

Exclusion Criteria

Pre existing neuropathy, contra indicatins to repeated PK sampling or EMG

Study & Design

• Study Type: Interventional
• Study Design: Not specified